Artículos disponibles en inglés, traducción en progreso
Tendencias en medicina regenerativa en minutos
Educación con respaldo científico redactada para profesionales de la salud. Actualizada regularmente.
Common Questions
Stem Cell Therapy Side Effects and Risks: What 55 Randomized Trials and the FDA Report
Stem cell therapy side effects and risks across 55 randomized trials with 2,696 patients, where documented serious harms came from, and six lot release tests.
Where Do Stem Cells Come From? Seven Sources and What Each One Yields
Where do stem cells come from? Seven sources, from bone marrow and fat to umbilical cord tissue and placenta, what each one yields and how it is tested.
Sermorelin vs Ipamorelin vs CJC-1295: Receptor Class, Half-Life and FDA Status Compared
Sermorelin vs ipamorelin vs CJC-1295: sermorelin and CJC-1295 act on the GHRH receptor, ipamorelin on the ghrelin receptor; half-lives run minutes to days.
How Long Do Peptides Take to Work? Half-Lives and Trial Timelines From the Studies
How long do peptides take to work? Lab markers like IGF-1 moved within weeks; trial outcomes were read months later. The timelines, peptide by peptide.
Are Peptides Legal in the US? The Three Routes, the 2026 Rules and the Paperwork
Are peptides legal in the US? Yes, through three routes: FDA-approved drugs, 503A compounding within the bulk lists, and IND trials. The 2026 changes, sourced.
Investigational Research
PRF vs PRP: Preparation, Growth-Factor Release, Clinical Evidence and Where Exosomes Fit
PRF vs PRP compared on spin, anticoagulant and growth-factor release, the facial, hair and rotator cuff trials, US regulatory status, and where exosomes fit.
Exosomes With Energy-Based Devices: What the Research Shows
Exosomes with energy-based devices: what fractional CO2, RF microneedling and picosecond studies report on channel timing, trial results and the FDA position.
Aesthetic Science
Exosomes or PRP for Facial Treatments: Method, Patient Selection, and the Depth That Governs Both
The one investigator-blinded split-face trial comparing the two materials on photoaged facial skin, how each is prepared, and the depth that governs both.
Topical Exosome Application in Aesthetic Practice
What peer-reviewed literature says about topical exosome application in aesthetic clinics: vesicle characterization, skin penetration and what documentation to ask a supplier for.
Hair Restoration Research
Scalp Microneedling and Topical Anesthesia: The Procedure Side of a Hair Protocol
What the 2024 and 2025 microneedling meta-analyses report, what four PRP meta-analyses since 2024 add and where spin protocol enters, what the exosome-after-needling scoping review and open-label study contain, what the topical anesthetic literature and one paper on platelets say, and what a microneedling device clearance covers: the needling itself. 16 sources, thirteen from 2011 onward.
Thyroid, Estrogens and Androgens: The Hormonal Context of Shedding in an Optimization Practice
What the thyroid literature reports about diffuse shedding, what the menopause and estrogen literature contains and why a 2026 systematic review had to untangle it, what the androgen literature reports in people receiving testosterone and in hyperandrogenic states, where the guidelines place the antiandrogen question in women, and what ExaVeyra does and does not supply. 16 sources, twelve from 2011 onward.
Biotin, Vitamin D and B12: Where Deficiency Matters and the Lab Notice Practices Miss
What four meta-analyses report on vitamin D deficiency across the alopecias, why the biotin reviews support supplementation only in documented deficiency, what the FDA warned about biotin and laboratory assays, what the iron and trace-element literature contains, and what a compounded injectable cofactor is. 14 sources, twelve from 2011 onward.
Thymosin Beta-4, TB-500, and Follicle Stem Cells: An Animal-Data Review
Why the hair literature belongs to thymosin beta-4, a 43-residue protein studied in rodents, goats and follicle cells, while TB-500 is a separate seven-residue fragment sold on that research; what the 2004 to 2021 animal work reports; why none of it transfers to a blend; and where the FDA lists the fragment. 14 sources, ten from 2011 onward.
Ketoconazole and Azelaic Acid as Scalp Adjuncts: Two Side Doors into the Hair Literature
What the 1998 shampoo study, two systematic reviews and the 2026 scalp-microbiome literature report for topical ketoconazole, what a single 1988 in vitro enzyme study means for azelaic acid, where the guidelines and network analyses place each, and what a compounded ketoconazole and niacinamide cream is under section 503A. 17 sources, twelve from 2011 onward.
Hair and Scalp Protocol Components 2026: What the Literature Supports for Each Formulation Class
A tiered map of finasteride, minoxidil combinations, ketoconazole and azelaic acid, GHK-Cu, thymosin beta-4, exosomes, nutritional and hormonal context and scalp procedures: what the peer-reviewed literature reports, what the FDA says about each, and what a licensed practice can source under which regime. 37 primary sources.
Exosomes at the Investigational Forefront of Hair Restoration
A clinician-facing review of MSC-derived exosome research in hair restoration: follicle biology, Wnt/beta-catenin signaling, the 2025 systematic reviews and registered trials, comparisons with PRP, available formats and documentation, and supplier due diligence. Expanded September 2026 with 18 sources.
Regenerative Science
Exosomes vs PRP: A Research Comparison for Practitioners
A side-by-side review of MSC-derived exosomes and platelet-rich plasma mechanism differences, evidence base, regulatory frameworks, and practical sourcing considerations for licensed clinicians.
What Are Exosomes? A Clinician's Guide to MSC-Derived Biologics
A structured primer on exosome biology for licensed practitioners: biogenesis, cargo composition, MSC source differences, manufacturing standards, and regulatory framing for clinical use.
Exosomes and Aesthetic Medicine: The Science Behind the Buzz
What peer-reviewed literature actually says about exosomes in aesthetic medicine: from exosome sourcing to the clinical trial landscape, and smart questions to ask your practitioner.
Hormone Optimization
503A Compounded Hormone Optimization: A Chemist's Guide to Supply Chain Integrity for HRT Clinics
A chemist-authored guide to 503A compounded HRT supply chain integrity covering testosterone, estradiol, progesterone, and growth hormone secretagogues. Peer-reviewed citations included.
Longevity Medicine
Pharmacy Regulations
2026 FDA 503A Peptide Category Changes: What Concierge and Longevity Clinics Need to Know
The FDA’s evolving review of bulk drug substances is reshaping which peptides 503A pharmacies can compound. A practitioner-focused guide to the category framework, the dated FDA actions of 2025 and 2026, and how to keep a peptide program compliant.
Regulatory & Compliance
Are Exosome Products FDA-Approved? The 2026 Legal and Compliance Landscape
A clear, current answer to the question clinics and patients ask most: are exosome products FDA-approved? Covers the regulatory status, the intended-use statement, and how to describe exosomes without crossing a claims line.
Practice Growth
Practitioner Guides
PRP Kit Buying Guide for Clinicians: What to Evaluate
A practitioner-facing review of centrifuge protocols, platelet yield, leukocyte content, closed vs open systems, activation methods, and supplier due diligence for in-office PRP preparation.
Regulatory Science
Stem Cell Sourcing for Florida Clinics: The Current Landscape
What Florida physicians need to know about stem cell sourcing under SB 1768, FDA 21 CFR Part 1271, cGMP requirements, and supply chain documentation standards.
Precision Medicine Research
When Genomics Meets Regeneration: What AI and Multi-Omics Bring to Cell Therapy Research
A peer-reviewed overview of how AI, multi-omics profiling, and genomic data are converging in cell therapy research and precision regenerative medicine, for licensed practitioners and research sponsors.
Dermatology Research
Exosomes in Dermatology: A Research Overview for Clinicians
A practitioner-facing review of MSC-derived exosome research in dermatology skin biology, post-procedure application context, and supplier due diligence for licensed practitioners.
El resumen mensual de la FDA y las leyes estatales
Un correo al mes para consultorios con licencia: acciones de la FDA, novedades sobre compuestos y cambios en las leyes estatales que afectan lo que usted puede adquirir, cada uno con su fuente oficial enlazada.
Sin spam. Cancele su suscripción en cualquier momento.
Profundizar
Más allá del blog: guías de abastecimiento para profesionales y referencias regulatorias detalladas.
Guía de abastecimiento
Abastecimiento de exosomas para clínicas
Requisitos de COA, estándares de caracterización analítica, señales de alerta de proveedores y puntos de referencia de calidad.
LeerGuía regulatoria
Formulación 503A y 503B
Guía completa de cumplimiento para el abastecimiento clínico de medicamentos magistrales.
LeerCiencia
Explorar la ciencia
Explorador 3D interactivo de exosomas, base de datos de publicaciones y mecanismo de acción.
Leer